CompletedNot applicableNCT00031850

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Studying Hereditary breast cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Cancer Research, United Kingdom
Principal Investigator
Anthony Howell, MD
The Christie NHS Foundation Trust
Intervention
goserelin acetate(drug)
Enrollment
150 enrolled
Eligibility
30-45 years · FEMALE
Timeline
20002007

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00031850 on ClinicalTrials.gov

Other trials for Hereditary breast cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary breast cancer

← Back to all trials